Phase II trial of FOLFOX6, bevacizumab, and cetuximab in the first-line treatment of metastatic colorectal cancer.
Year: 2010
Type: article
Study design: Clinical Trial
Source: PubMed
Institution: Sarah Cannon
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W160400900
